Related references
Note: Only part of the references are listed.The WHO 2014 Global tuberculosis report-further to go
Alimuddin Zumla et al.
LANCET GLOBAL HEALTH (2015)
Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis
Hannah A. Blair et al.
DRUGS (2015)
The Antituberculosis Antibiotic Capreomycin Inhibits Protein Synthesis by Disrupting Interaction between Ribosomal Proteins L12 and L10
Yuan Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis
Mayara L. Bastos et al.
CLINICAL INFECTIOUS DISEASES (2014)
Structural states of the flexible catalytic loop of M-tuberculosis tyrosyl-tRNA synthetase in different enzyme-substrate complexes
Vasyl V. Mykuliak et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2014)
Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives
Shengtao Xu et al.
FITOTERAPIA (2014)
Identification of anti-tuberculosis agents that target the cell-division protein FtsZ
Yuan Lin et al.
JOURNAL OF ANTIBIOTICS (2014)
Bedaquiline: A novel antitubercular drug for multidrug-resistant tuberculosis
H. Nagabushan et al.
JOURNAL OF POSTGRADUATE MEDICINE (2014)
Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS
Johayra Simithy et al.
TUBERCULOSIS (2014)
Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme
Qosay A. Al-Balas et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: Synthesis, molecular docking and antibacterial evaluation
Xu-Dong Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present
Bharat Gadakh et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system
Yuan Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
4-Alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: Synthesis, molecular docking and antibacterial evaluation
Zhu-Ping Xiao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: Synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones
Zhu-Ping Xiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
A paralog of lysyl-tRNA synthetase aminoacylates a conserved lysine residue in translation elongation factor P
Tatsuo Yanagisawa et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Synthetic Microcin C Analogs Targeting Different Aminoacyl-tRNA Synthetases
Pieter Van de Vijver et al.
JOURNAL OF BACTERIOLOGY (2009)
SPR-based fragment screening: Advantages and applications
T. Neumann et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Evolution of the tRNATYr/TyrRS aminoacylation systems
L Bonnefond et al.
BIOCHIMIE (2005)
Structural snapshots of the KMSKS loop rearrangement for amino acid activation by bacterial tyrosyl-tRNA synthetase
T Kobayashi et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Class I tyrosyl-tRNA synthetase has a class II mode of cognate tRNA recognition
A Yaremchuk et al.
EMBO JOURNAL (2002)
Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors
XY Qiu et al.
PROTEIN SCIENCE (2001)
Share Paper
